Aims The Acute Cardiac Care Association (ACCA)-European Association of Percutaneous
Coronary Intervention (EAPCI) Registry on ST-elevation myocardial infarction (STEMI)
of the EurObservational programme (EORP) of the European Society of Cardiology (ESC)
registry aimed to determine the current state of the use of reperfusion therapy in
ESC member and ESC affiliated countries and the adherence to ESC STEMI guidelines
in patients with STEMI. Methods and results Between 1 January 2015 and 31 March 2018,
a total of 11 462 patients admitted with an initial diagnosis of STEMI according to
the 2012 ESC STEMI guidelines were enrolled. Individual patient data were collected
across 196 centres and 29 countries. Among the centres, there were 136 percutaneous
coronary intervention centres and 91 with cardiac surgery on-site. The majority of
centres (129/196) were part of a STEMI network. The main objective of this study was
to describe the demographic, clinical, and angiographic characteristics of patients
with STEMI. Other objectives include to assess management patterns and in particular
the current use of reperfusion therapies and to evaluate how recommendations of most
recent STEMI European guidelines regarding reperfusion therapies and adjunctive pharmacological
and non-pharmacological treatments are adopted in clinical practice and how their
application can impact on patients' outcomes. Patients will be followed for 1 year
after admission. Conclusion The ESC ACCA-EAPCI EORP ACS STEMI registry is an international
registry of care and outcomes of patients hospitalized with STEMI. It will provide
insights into the contemporary patient profile, management patterns, and 1-year outcome
of patients with STEMI.
